DIN 02451034 — KYPROLIS 60 MG
KYPROLIS is a powder for solution of Carfilzomib marketed by AMGEN CANADA INC. The full Carfilzomib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02451034
- Brand name
- KYPROLIS
- Active ingredient
- Carfilzomib
- Strength
- 60 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- AMGEN CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Proteasome inhibitor (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Carfilzomib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02459930 | KYPROLIS | 10 MG | POWDER FOR SOLUTION | AMGEN CANADA INC | MARKETED |
| 02459949 | KYPROLIS | 30 MG | POWDER FOR SOLUTION | AMGEN CANADA INC | MARKETED |